Clinical Trials · NCT00217659
S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- SWOG Cancer Research Network
- Enrollment
- 0
- Start date
- Sep 2005
- Locations
- 57 sites, United States
- Primary endpoint
- Progression-free survival (PFS)